mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |